106 related articles for article (PubMed ID: 34628102)
1. IDO activity forecasts obesity in males and premenopausal females in a 10-year follow-up study:The Cardiovascular Risk in Young Finns Study.
Niinisalo P; Raitakari OT; Kähönen M; Hurme M; Lehtimäki T; Magnussen C; Viikari J; Juonala M; Kaaja R
Atherosclerosis; 2021 Nov; 336():32-38. PubMed ID: 34628102
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.
Pertovaara M; Raitala A; Juonala M; Lehtimäki T; Huhtala H; Oja SS; Jokinen E; Viikari JS; Raitakari OT; Hurme M
Clin Exp Immunol; 2007 Apr; 148(1):106-11. PubMed ID: 17349013
[TBL] [Abstract][Full Text] [Related]
3. Effect modification of general and central obesity by sex and age on cardiovascular outcomes: Targeted maximum likelihood estimation in the atherosclerosis risk in communities study.
Mozafar Saadati H; Sabour S; Mansournia MA; Mehrabi Y; Hashemi Nazari SS
Diabetes Metab Syndr; 2021; 15(2):479-485. PubMed ID: 33662834
[TBL] [Abstract][Full Text] [Related]
4. Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: evidence from the Young Finns study.
Elovainio M; Hurme M; Jokela M; Pulkki-Råback L; Kivimäki M; Hintsanen M; Hintsa T; Lehtimäki T; Viikari J; Raitakari OT; Keltikangas-Järvinen L
J Affect Disord; 2011 Oct; 133(3):611-4. PubMed ID: 21600662
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study.
Niinisalo P; Raitala A; Pertovaara M; Oja SS; Lehtimäki T; Kähönen M; Reunanen A; Jula A; Moilanen L; Kesäniemi YA; Nieminen MS; Hurme M
Scand J Clin Lab Invest; 2008; 68(8):767-70. PubMed ID: 18622801
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation.
Suarez-Fuentetaja N; Domenech-Garcia N; Paniagua-Martin MJ; Marzoa-Rivas R; Barge-Caballero E; Grille-Cancela Z; Pombo-Otero J; Muñiz-García J; Castro-Beiras A; Crespo-Leiro MG
Transplant Proc; 2012 Nov; 44(9):2645-8. PubMed ID: 23146482
[TBL] [Abstract][Full Text] [Related]
7. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.
Dansinger ML; Williams PT; Superko HR; Schaefer EJ
Lipids Health Dis; 2019 Jul; 18(1):154. PubMed ID: 31311555
[TBL] [Abstract][Full Text] [Related]
8. Associations between estimated aerobic fitness and cardiovascular risk factors in adults with different levels of abdominal obesity.
Borodulin K; Laatikainen T; Lahti-Koski M; Lakka TA; Laukkanen R; Sarna S; Jousilahti P
Eur J Cardiovasc Prev Rehabil; 2005 Apr; 12(2):126-31. PubMed ID: 15785297
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the Young Finns Study.
Elovainio M; Hurme M; Jokela M; Pulkki-Råback L; Kivimäki M; Hintsanen M; Hintsa T; Lehtimäki T; Viikari J; Raitakari OT; Keltikangas-Järvinen L
Psychosom Med; 2012 Sep; 74(7):675-81. PubMed ID: 22929065
[TBL] [Abstract][Full Text] [Related]
10. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study.
Raitakari OT; Juonala M; Viikari JS
Int J Obes (Lond); 2005 Sep; 29 Suppl 2():S101-4. PubMed ID: 16385760
[TBL] [Abstract][Full Text] [Related]
11. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference.
Juonala M; Viikari JS; Hutri-Kähönen N; Pietikäinen M; Jokinen E; Taittonen L; Marniemi J; Rönnemaa T; Raitakari OT
J Intern Med; 2004 Apr; 255(4):457-68. PubMed ID: 15049880
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey.
Jylhävä J; Haarala A; Kähönen M; Lehtimäki T; Jula A; Moilanen L; Kesäniemi YA; Nieminen MS; Hurme M
Clin Exp Immunol; 2011 May; 164(2):211-7. PubMed ID: 21391986
[TBL] [Abstract][Full Text] [Related]
13. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
16. The High Prevalence of Low HDL-Cholesterol Levels and Dyslipidemia in Rural Populations in Northwestern China.
Ge P; Dong C; Ren X; Weiderpass E; Zhang C; Fan H; Zhang J; Zhang Y; Xi J
PLoS One; 2015; 10(12):e0144104. PubMed ID: 26640891
[TBL] [Abstract][Full Text] [Related]
17. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
18. [Gender difference in association between smoking and metabolic risks among community adults].
Wang JW; Hu DY; Sun YH; Wang JH; Xie J
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):805-9. PubMed ID: 21600158
[TBL] [Abstract][Full Text] [Related]
19. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
20. Overview of epidemiology and contribution of obesity to cardiovascular disease.
Bastien M; Poirier P; Lemieux I; Després JP
Prog Cardiovasc Dis; 2014; 56(4):369-81. PubMed ID: 24438728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
